Inhibitory nonsequence-specific effects of cytidine homopolymers on in vivo neointimal formation

Antisense and Nucleic Acid Drug Development

Volumn 7, Issue 6, 2009, Pages 559-566

  Wang, Weizheng ^a   Chen, Hong Jun ^a   Schwartz, Allan ^a   Cannon, Paul J ^a   Stein, C A ^a   Rabbani, LeRoy E ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTIDINE; PLATELET DERIVED GROWTH FACTOR;

ANIMAL EXPERIMENT; ARTERY INJURY; ARTERY INTIMA; ARTERY MEDIA; ARTERY WALL; ARTICLE; CAROTID ARTERY; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALIA;

EID: 0031472670     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.1.1997.7.559     Document Type: Article

References (10)

1. BENNETT, M.R., ANGLIN, S., McEWAN, J.R., JAGOE NEWBY, R.A.C., and EVAN, G.I. (1993). Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligonucleotides. J. Clin. Invest. 93, 820-828.
2. BIRO, S., FU, Y.M., YU, Z.X., and EPSTEIN, S.E. (1993). Inhibitory effects of antisense oligonucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration. Proc. Natl. Acad. Sci. USA 90, 654-658.
3. BROWN, K.E., KINDY, M.S., and SONENSHEIN, G.E. (1992). Expression of the c-myc protooncogene in bovine vascular smooth muscle cells. J. Biol. Chem. 267, 4625-4630.
4. BURGESS, T.L., FISHER, E.F., ROSS, S.L., BREADY, J.V., QIAN, Y.-X., BAYEWITCH, L.A., COHEN, A.M., HERRERA, C.J., HU, S.S.-F., KRAMER, T.B., LOTT, F.D., MARTIN, F.H., PIERCE, G.F., SIMONET, L., and FARRELL, C.L. (1995). The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proc. Natl. Acad. Sci. USA 92, 4051-1055.
5. LINDNER, V., LAPPI, D.A., BAIRD, A., MAJACK, R.A., and REIDY, M.A. (1991). Role of basic fibroblast growth factor in vascular lesion formation. Circ. Res. 68, 106-113.
6. LINDNER, V., and REIDY, M.A. (1991). Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc. Natl. Acad. Sci. USA 88, 3739-3743.
7. McNEIL, P.L., MUTHUKRISHNAN, L., WARDER, E., and D'AMORE, P.A. (1989). Growth factors are released by mechanically wounded endothelial cells. J. Cell. Biol. 109, 811-822.
8. PRESTRELSKI, S.J., FOX, G.M., and ARAKAWA, T. (1992). Binding of heparin to basic fibroblast growth factor induces a conformational change. Arch. Biochem. Biophys. 293, 314-319.
9. ROGERS, C., KARNOVSKY, M.J., and EDELMAN, E.R. (1993). Inhibition of experimental neointimal hyperplasia and thrombosis depends on the type of vascular injury and the site of drug administration. Circulation 88, 1215-1221.
10. SHI, Y., FARD, A., GALEO, A., HUTCHINSON, H.G., VERNANI, P., DODGE, G.R., HALL, D.J., SHAHEEN, F., ZALEWSKI, A. (1994). Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury. Circulation 90, 944-951.